IN2014CN02984A - - Google Patents
Info
- Publication number
- IN2014CN02984A IN2014CN02984A IN2984CHN2014A IN2014CN02984A IN 2014CN02984 A IN2014CN02984 A IN 2014CN02984A IN 2984CHN2014 A IN2984CHN2014 A IN 2984CHN2014A IN 2014CN02984 A IN2014CN02984 A IN 2014CN02984A
- Authority
- IN
- India
- Prior art keywords
- polymer
- occlusive
- layers
- active ingredient
- slightly
- Prior art date
Links
- 229920000642 polymer Polymers 0.000 abstract 3
- 239000004480 active ingredient Substances 0.000 abstract 2
- 229920005601 base polymer Polymers 0.000 abstract 2
- 239000011159 matrix material Substances 0.000 abstract 1
- 230000035699 permeability Effects 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive bandages or dressings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
- A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/225—Mixtures of macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/48—Surfactants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/58—Adhesives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Materials Engineering (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Polymers & Plastics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The invention relates to a transdermal or topical plasters that contain active ingredient comprising a non occlusive back layer a matrix composed of one or more polymer layers having at least one pharmaceutical active ingredient in one or more of the layers wherein the structure forming base polymers of the layer(s) are non occlusive or only slightly occlusive and a second polymer that has a low water vapor permeability and that is immiscible or only very slightly miscible with the base polymer is dispersed in at least one of the polymer layers.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102011114411A DE102011114411A1 (en) | 2011-09-26 | 2011-09-26 | Plaster with adjustable occlusion |
PCT/EP2012/068828 WO2013045420A1 (en) | 2011-09-26 | 2012-09-25 | Plaster having adjustable occlusion |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2014CN02984A true IN2014CN02984A (en) | 2015-07-03 |
Family
ID=46924436
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN2984CHN2014 IN2014CN02984A (en) | 2011-09-26 | 2012-09-25 |
Country Status (14)
Country | Link |
---|---|
US (1) | US9180103B2 (en) |
EP (1) | EP2760436B1 (en) |
JP (1) | JP6033309B2 (en) |
KR (1) | KR101945573B1 (en) |
CN (2) | CN103826619A (en) |
AU (1) | AU2012314560C1 (en) |
BR (1) | BR112014007210B1 (en) |
CA (1) | CA2849956C (en) |
DE (1) | DE102011114411A1 (en) |
ES (1) | ES2755728T3 (en) |
IN (1) | IN2014CN02984A (en) |
MX (1) | MX338901B (en) |
RU (1) | RU2616524C2 (en) |
WO (1) | WO2013045420A1 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20170136124A1 (en) * | 2015-11-16 | 2017-05-18 | Noven Pharmaceuticals, Inc. | Stretchable backing layers for transdermal drug delivery systems |
US20190240167A1 (en) * | 2016-10-18 | 2019-08-08 | Lts Lohmann Therapie-Systeme Ag | Two-layer topical therapeutic system |
EP3384904A1 (en) | 2017-04-03 | 2018-10-10 | tesa Labtec GmbH | Pharmaceutical preparation for dermal administration |
RU2705896C1 (en) * | 2019-07-26 | 2019-11-12 | Артем Олегович Бахметьев | Transdermal plaster |
DE102021128912A1 (en) * | 2021-11-05 | 2023-05-11 | Lts Lohmann Therapie-Systeme Ag. | OCLUSIVE PLASTER WITH FLEXIBLE BACKING |
DE102021128911A1 (en) * | 2021-11-05 | 2023-05-11 | Lts Lohmann Therapie-Systeme Ag. | DICLOFENAC CONTAINING TTS WITH DIMETHYLPROPYLENE UREA |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5474783A (en) * | 1988-03-04 | 1995-12-12 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
US4814168A (en) * | 1988-03-04 | 1989-03-21 | Noven Pharmaceuticals, Inc. | Transdermal multipolymer drug delivery system |
US4994267A (en) * | 1988-03-04 | 1991-02-19 | Noven Pharmaceuticals, Inc. | Transdermal acrylic multipolymer drug delivery system |
CN1151780C (en) * | 1993-01-02 | 2004-06-02 | 诺纹制药股份有限公司 | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
DE10027258C1 (en) * | 2000-05-31 | 2001-10-31 | Lohmann Therapie Syst Lts | Transdermal therapeutic system, for local/systemic delivery of non-steroidal antiinflammatory agents, comprises a permeable, elastic water and air permeable backing layer and an impermeable two-phase drug-containing matrix layer |
DE10060550C1 (en) * | 2000-12-06 | 2002-04-18 | Lohmann Therapie Syst Lts | Transdermal therapeutic system for administration of oxybutynin, especially for treatment of bladder dysfunction, having two-phase matrix layer of active agent-containing droplets dispersed in adhesive |
DE10103860B4 (en) * | 2001-01-30 | 2004-12-23 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system for the administration of carboxyl group-containing, non-steroidal anti-inflammatory drugs, and process for its preparation |
CN1250206C (en) * | 2001-03-07 | 2006-04-12 | 久光制药株式会社 | Adhesive patch |
CA2565838A1 (en) | 2004-05-07 | 2005-11-17 | Asahi Glass Company, Limited | Single-sealed multilayer transparent unit |
DE102006019293A1 (en) * | 2006-04-21 | 2007-10-25 | LABTEC Gesellschaft für technologische Forschung und Entwicklung mbH | Transdermal therapeutic system, useful for pain treatment, comprises a carrier layer, an adhesive layer comprising a pressure sensitive copolymer with a content of fentanyl and analogs and a removable protection layer |
US8647664B2 (en) * | 2006-07-14 | 2014-02-11 | Hisamitsu Pharmaceutical Co., Inc. | Adhesive preparation |
DE102006054733A1 (en) * | 2006-11-21 | 2008-05-29 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system with high drug utilization rate and dosing accuracy |
-
2011
- 2011-09-26 DE DE102011114411A patent/DE102011114411A1/en not_active Withdrawn
-
2012
- 2012-09-25 IN IN2984CHN2014 patent/IN2014CN02984A/en unknown
- 2012-09-25 WO PCT/EP2012/068828 patent/WO2013045420A1/en active Application Filing
- 2012-09-25 KR KR1020147011086A patent/KR101945573B1/en active IP Right Grant
- 2012-09-25 CN CN201280046758.8A patent/CN103826619A/en active Pending
- 2012-09-25 EP EP12762597.8A patent/EP2760436B1/en active Active
- 2012-09-25 BR BR112014007210-8A patent/BR112014007210B1/en active IP Right Grant
- 2012-09-25 AU AU2012314560A patent/AU2012314560C1/en active Active
- 2012-09-25 CA CA2849956A patent/CA2849956C/en active Active
- 2012-09-25 RU RU2014116821A patent/RU2616524C2/en active
- 2012-09-25 CN CN201710819641.3A patent/CN107595818A/en active Pending
- 2012-09-25 JP JP2014531268A patent/JP6033309B2/en active Active
- 2012-09-25 MX MX2014003669A patent/MX338901B/en active IP Right Grant
- 2012-09-25 US US14/346,527 patent/US9180103B2/en active Active
- 2012-09-25 ES ES12762597T patent/ES2755728T3/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN103826619A (en) | 2014-05-28 |
DE102011114411A1 (en) | 2013-03-28 |
EP2760436B1 (en) | 2019-09-18 |
WO2013045420A1 (en) | 2013-04-04 |
KR101945573B1 (en) | 2019-02-07 |
KR20140072128A (en) | 2014-06-12 |
AU2012314560C1 (en) | 2016-10-06 |
JP6033309B2 (en) | 2016-11-30 |
EP2760436A1 (en) | 2014-08-06 |
US9180103B2 (en) | 2015-11-10 |
MX338901B (en) | 2016-05-03 |
AU2012314560A1 (en) | 2014-05-15 |
RU2014116821A (en) | 2015-11-10 |
BR112014007210B1 (en) | 2021-12-21 |
CN107595818A (en) | 2018-01-19 |
BR112014007210A2 (en) | 2017-04-04 |
JP2014526546A (en) | 2014-10-06 |
CA2849956A1 (en) | 2013-04-04 |
MX2014003669A (en) | 2014-04-30 |
CA2849956C (en) | 2019-09-03 |
ES2755728T3 (en) | 2020-04-23 |
AU2012314560B2 (en) | 2016-02-18 |
US20140234395A1 (en) | 2014-08-21 |
RU2616524C2 (en) | 2017-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2014CN02984A (en) | ||
WO2014108571A3 (en) | Cancer drug and uses | |
UY33396A (en) | 5-FLUORO-1H-REPLACED PIRAZOLOPIRIDINES AND ITS USE | |
MX346337B (en) | Nanopatterned medical device with enhanced cellular interaction. | |
CL2015003022A1 (en) | Use of empagliflozin in the preparation of a useful medication in the treatment of chronic kidney disease | |
MX345344B (en) | Transdermal therapeutic system for administering an active substance. | |
CL2013000423A1 (en) | Pharmaceutical dosage form with breaking strength of at least 500 n, which contains an active ingredient, an anionic polysaccharide and a polyalkylene oxide, wherein the active ingredient is present in a controlled release matrix comprising the anionic polysaccharide and the oxide of polyalkylene. | |
CL2013000058A1 (en) | Use of polypeptide factor ix to control or prevent bleeding in minor hemorrhages, hemarthrosis, superficial muscle hemorrhage, among others. | |
BR112012024835A2 (en) | transdermal patch adhesive | |
PE20142035A1 (en) | COMPOSITE FORMULATION INCLUDING A MULTIPLE UNITS SPHEROIDAL TABLET (MUST) ENCAPSULATED IN A HARD CAPSULE AND A METHOD TO PREPARE THE SAME | |
MX2015000114A (en) | Extended release, abuse deterrent pharmaceutical compositions. | |
MY163809A (en) | Transdermal drug delivery system containing donepezil | |
CL2013003700A1 (en) | Topical ophthalmological pharmaceutical composition comprising regorafenib, which is suspended in a pharmaceutically acceptable vehicle; manufacturing procedure and its use to treat or prevent an ophthalmological disorder. | |
EA201591830A1 (en) | PHARMACEUTICAL COMPOSITIONS, INCLUDING EVEROLIMUS | |
AR094289A1 (en) | SYSTEMS OF TRANSDERMAL ADMINISTRATION OF PHARMACOS FOR LEVONORGESTREL AND ETINIL ESTRADIOL | |
PH12015502280A1 (en) | Transdermal delivery system comprising donepezil or its salt | |
EA201690679A1 (en) | STABLE PHARMACEUTICAL COMPOSITION CONTAINING AMLODIPIPIN AND VALSARTAN | |
CL2014003525A1 (en) | Pharmaceutical composition comprising fimasartan, hydrochlorothiazide and a binder; preparation procedure; its use in the treatment of hypertension. | |
NZ709521A (en) | Transdermal dosage form for low-melting point active agent | |
IN2014DN06817A (en) | ||
MX2020003665A (en) | Transdermal therapeutic system for the transdermal administration of guanfacine comprising at least one additive. | |
WO2012111996A3 (en) | Transdermal delivery system containing galantamine or salts thereof | |
PH12015500451A1 (en) | Adhesive skin patch | |
WO2013102842A3 (en) | Device and composition for drug release | |
MX2012012930A (en) | Topical pharmaceutical composition comprising heparin. |